Michael Lawrence Barnett, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skilled Nursing Facilities | 15 | 2024 | 398 | 6.000 |
Why?
|
Analgesics, Opioid | 22 | 2024 | 3808 | 3.540 |
Why?
|
Opioid-Related Disorders | 20 | 2024 | 2164 | 3.200 |
Why?
|
Medicare | 48 | 2024 | 6770 | 3.140 |
Why?
|
Telemedicine | 18 | 2023 | 3051 | 2.480 |
Why?
|
Nursing Homes | 10 | 2024 | 1082 | 2.400 |
Why?
|
Drug Prescriptions | 12 | 2024 | 1670 | 2.360 |
Why?
|
Primary Health Care | 19 | 2022 | 4686 | 2.180 |
Why?
|
Nurse Practitioners | 6 | 2023 | 271 | 2.150 |
Why?
|
Buprenorphine | 9 | 2023 | 656 | 2.120 |
Why?
|
Physicians | 18 | 2024 | 4591 | 2.110 |
Why?
|
Specialization | 8 | 2021 | 778 | 2.070 |
Why?
|
Reimbursement Mechanisms | 7 | 2021 | 667 | 2.010 |
Why?
|
Narcotic Antagonists | 6 | 2023 | 585 | 1.810 |
Why?
|
Ambulatory Care | 9 | 2024 | 2775 | 1.770 |
Why?
|
United States | 100 | 2024 | 72334 | 1.720 |
Why?
|
Medicare Part C | 7 | 2024 | 334 | 1.700 |
Why?
|
Remote Consultation | 3 | 2021 | 237 | 1.590 |
Why?
|
Physicians, Primary Care | 9 | 2022 | 623 | 1.580 |
Why?
|
Physician Assistants | 4 | 2023 | 191 | 1.410 |
Why?
|
Medicine | 5 | 2022 | 942 | 1.360 |
Why?
|
Residential Treatment | 2 | 2021 | 111 | 1.350 |
Why?
|
Referral and Consultation | 8 | 2022 | 3600 | 1.130 |
Why?
|
Nursing Staff | 3 | 2021 | 113 | 1.060 |
Why?
|
Fee-for-Service Plans | 8 | 2022 | 700 | 1.040 |
Why?
|
Health Services Accessibility | 11 | 2022 | 5440 | 1.020 |
Why?
|
Subacute Care | 4 | 2020 | 179 | 0.970 |
Why?
|
Long-Term Care | 4 | 2024 | 633 | 0.930 |
Why?
|
Medicaid | 7 | 2024 | 2818 | 0.930 |
Why?
|
Respiratory Tract Infections | 5 | 2023 | 1010 | 0.890 |
Why?
|
Pandemics | 21 | 2024 | 8654 | 0.870 |
Why?
|
Humans | 147 | 2024 | 761504 | 0.840 |
Why?
|
Delivery of Health Care | 6 | 2023 | 5336 | 0.820 |
Why?
|
Interprofessional Relations | 4 | 2019 | 990 | 0.810 |
Why?
|
Ivermectin | 1 | 2022 | 46 | 0.800 |
Why?
|
Health Expenditures | 7 | 2021 | 2366 | 0.770 |
Why?
|
Health Facility Administrators | 1 | 2021 | 32 | 0.740 |
Why?
|
Insurance Coverage | 4 | 2023 | 1940 | 0.740 |
Why?
|
Aged | 58 | 2024 | 169289 | 0.730 |
Why?
|
Personnel Turnover | 1 | 2021 | 88 | 0.710 |
Why?
|
Mythology | 1 | 2020 | 15 | 0.710 |
Why?
|
Arthroplasty, Replacement | 2 | 2020 | 310 | 0.700 |
Why?
|
Economics, Hospital | 2 | 2019 | 210 | 0.690 |
Why?
|
Dental Care | 1 | 2023 | 285 | 0.680 |
Why?
|
Infection Control | 3 | 2021 | 981 | 0.660 |
Why?
|
Patient Transfer | 3 | 2017 | 794 | 0.630 |
Why?
|
Health Personnel | 4 | 2023 | 3335 | 0.630 |
Why?
|
Patient Discharge | 8 | 2024 | 3443 | 0.630 |
Why?
|
Gatekeeping | 1 | 2018 | 49 | 0.630 |
Why?
|
Preferred Provider Organizations | 1 | 2018 | 38 | 0.630 |
Why?
|
Benzodiazepines | 3 | 2023 | 1132 | 0.620 |
Why?
|
Heroin Dependence | 1 | 2019 | 172 | 0.620 |
Why?
|
Insurance, Health | 4 | 2023 | 2498 | 0.610 |
Why?
|
Oxycodone | 2 | 2022 | 139 | 0.610 |
Why?
|
Dementia | 3 | 2024 | 2686 | 0.600 |
Why?
|
Pharyngitis | 2 | 2024 | 219 | 0.600 |
Why?
|
Guideline Adherence | 3 | 2021 | 2220 | 0.600 |
Why?
|
Hydroxychloroquine | 1 | 2022 | 426 | 0.590 |
Why?
|
Drug Utilization | 4 | 2020 | 1188 | 0.590 |
Why?
|
Outpatients | 8 | 2024 | 1597 | 0.580 |
Why?
|
Government Regulation | 2 | 2020 | 524 | 0.570 |
Why?
|
Anti-Bacterial Agents | 9 | 2024 | 7407 | 0.570 |
Why?
|
Back Pain | 1 | 2021 | 545 | 0.570 |
Why?
|
Managed Care Programs | 3 | 2018 | 940 | 0.560 |
Why?
|
Health Services Research | 4 | 2019 | 1812 | 0.560 |
Why?
|
Substance-Related Disorders | 4 | 2022 | 4420 | 0.560 |
Why?
|
Quality of Health Care | 5 | 2023 | 4330 | 0.550 |
Why?
|
Salaries and Fringe Benefits | 1 | 2019 | 257 | 0.540 |
Why?
|
Psychiatry | 4 | 2022 | 1693 | 0.530 |
Why?
|
Rural Health Services | 1 | 2019 | 384 | 0.520 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3084 | 0.520 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3204 | 0.510 |
Why?
|
Health Maintenance Organizations | 1 | 2018 | 659 | 0.510 |
Why?
|
Antibodies, Monoclonal | 2 | 2023 | 9177 | 0.510 |
Why?
|
Inappropriate Prescribing | 5 | 2024 | 211 | 0.510 |
Why?
|
Antipsychotic Agents | 4 | 2024 | 3067 | 0.500 |
Why?
|
Medically Uninsured | 2 | 2019 | 836 | 0.500 |
Why?
|
Cross-Sectional Studies | 15 | 2024 | 26125 | 0.490 |
Why?
|
Medical Staff, Hospital | 1 | 2019 | 601 | 0.480 |
Why?
|
Behavior Therapy | 1 | 2020 | 879 | 0.480 |
Why?
|
Male | 58 | 2024 | 360804 | 0.470 |
Why?
|
Home Care Services | 1 | 2021 | 648 | 0.460 |
Why?
|
Education, Medical | 2 | 2023 | 1725 | 0.460 |
Why?
|
Policy Making | 1 | 2017 | 542 | 0.450 |
Why?
|
Cost Savings | 1 | 2019 | 913 | 0.450 |
Why?
|
Intelligence | 1 | 2019 | 924 | 0.450 |
Why?
|
Accreditation | 1 | 2017 | 473 | 0.450 |
Why?
|
Female | 58 | 2024 | 392644 | 0.440 |
Why?
|
Bronchitis | 1 | 2014 | 196 | 0.440 |
Why?
|
Disease Outbreaks | 1 | 2023 | 1749 | 0.440 |
Why?
|
Health Plan Implementation | 1 | 2016 | 337 | 0.430 |
Why?
|
Education | 1 | 2016 | 537 | 0.420 |
Why?
|
Personal Satisfaction | 1 | 2017 | 644 | 0.420 |
Why?
|
Patient Admission | 1 | 2020 | 1367 | 0.420 |
Why?
|
Opiate Substitution Treatment | 6 | 2024 | 444 | 0.420 |
Why?
|
Electronic Health Records | 4 | 2020 | 4811 | 0.410 |
Why?
|
Prescriptions | 4 | 2023 | 386 | 0.410 |
Why?
|
Aftercare | 2 | 2023 | 914 | 0.410 |
Why?
|
Population Surveillance | 1 | 2023 | 2598 | 0.410 |
Why?
|
Hospital-Physician Joint Ventures | 1 | 2012 | 30 | 0.400 |
Why?
|
Hospitals | 5 | 2019 | 3882 | 0.400 |
Why?
|
Cause of Death | 2 | 2022 | 3683 | 0.390 |
Why?
|
Appointments and Schedules | 3 | 2021 | 443 | 0.390 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2021 | 1393 | 0.390 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1505 | 0.390 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1265 | 0.380 |
Why?
|
Hospitalization | 7 | 2024 | 10723 | 0.380 |
Why?
|
Drug Industry | 1 | 2017 | 788 | 0.370 |
Why?
|
Office Visits | 4 | 2022 | 595 | 0.370 |
Why?
|
Antiviral Agents | 1 | 2023 | 3060 | 0.360 |
Why?
|
Emergency Service, Hospital | 7 | 2024 | 7879 | 0.360 |
Why?
|
Patient Readmission | 4 | 2019 | 3270 | 0.360 |
Why?
|
Health Care Surveys | 4 | 2020 | 2426 | 0.350 |
Why?
|
Healthcare Disparities | 2 | 2023 | 3358 | 0.340 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4016 | 0.340 |
Why?
|
Health Policy | 2 | 2022 | 2684 | 0.330 |
Why?
|
Health Status | 1 | 2022 | 4077 | 0.330 |
Why?
|
Middle Aged | 32 | 2024 | 220895 | 0.320 |
Why?
|
Motivation | 1 | 2019 | 2006 | 0.320 |
Why?
|
Caregivers | 1 | 2021 | 2237 | 0.310 |
Why?
|
Veterans | 2 | 2019 | 2647 | 0.310 |
Why?
|
Aged, 80 and over | 18 | 2024 | 58976 | 0.300 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2019 | 1413 | 0.300 |
Why?
|
Inpatients | 2 | 2017 | 2548 | 0.300 |
Why?
|
Adult | 29 | 2024 | 221177 | 0.290 |
Why?
|
Emergency Medicine | 1 | 2017 | 1198 | 0.290 |
Why?
|
Patients | 3 | 2023 | 907 | 0.280 |
Why?
|
Patient Acceptance of Health Care | 2 | 2021 | 3205 | 0.280 |
Why?
|
Diagnosis-Related Groups | 2 | 2021 | 449 | 0.280 |
Why?
|
Memory | 1 | 2017 | 2188 | 0.280 |
Why?
|
Rural Population | 4 | 2021 | 2285 | 0.280 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2169 | 0.270 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3461 | 0.260 |
Why?
|
Length of Stay | 3 | 2023 | 6425 | 0.260 |
Why?
|
Hospital Costs | 1 | 2012 | 947 | 0.260 |
Why?
|
Mortality | 1 | 2017 | 2901 | 0.250 |
Why?
|
Students, Medical | 1 | 2019 | 1936 | 0.250 |
Why?
|
Cohort Studies | 10 | 2024 | 41487 | 0.250 |
Why?
|
Clinical Competence | 1 | 2021 | 4792 | 0.250 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2759 | 0.250 |
Why?
|
Young Adult | 12 | 2024 | 59243 | 0.250 |
Why?
|
Mental Health | 1 | 2019 | 3250 | 0.250 |
Why?
|
Baclofen | 2 | 2022 | 120 | 0.230 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7045 | 0.220 |
Why?
|
Health Facilities | 2 | 2020 | 580 | 0.220 |
Why?
|
Vulnerable Populations | 2 | 2020 | 703 | 0.210 |
Why?
|
Carisoprodol | 1 | 2022 | 5 | 0.210 |
Why?
|
Methocarbamol | 1 | 2022 | 8 | 0.210 |
Why?
|
Ritonavir | 1 | 2024 | 329 | 0.210 |
Why?
|
Advanced Practice Nursing | 1 | 2022 | 18 | 0.200 |
Why?
|
Mental Disorders | 5 | 2023 | 6845 | 0.200 |
Why?
|
Episode of Care | 2 | 2021 | 128 | 0.200 |
Why?
|
Specialty Boards | 1 | 2023 | 235 | 0.190 |
Why?
|
Databases, Factual | 4 | 2021 | 7967 | 0.190 |
Why?
|
Streptococcus pyogenes | 1 | 2024 | 292 | 0.190 |
Why?
|
Retrospective Studies | 11 | 2024 | 80636 | 0.190 |
Why?
|
Essential Tremor | 1 | 2024 | 157 | 0.190 |
Why?
|
Physicians' Offices | 1 | 2021 | 60 | 0.190 |
Why?
|
Subthalamic Nucleus | 1 | 2024 | 195 | 0.190 |
Why?
|
Health Facilities, Proprietary | 1 | 2021 | 37 | 0.190 |
Why?
|
New York City | 2 | 2020 | 731 | 0.180 |
Why?
|
Texas | 1 | 2022 | 404 | 0.180 |
Why?
|
Naltrexone | 1 | 2023 | 317 | 0.180 |
Why?
|
Neuromuscular Agents | 1 | 2022 | 147 | 0.180 |
Why?
|
Lorazepam | 1 | 2021 | 154 | 0.180 |
Why?
|
Naloxone | 1 | 2023 | 370 | 0.180 |
Why?
|
Organizations, Nonprofit | 1 | 2021 | 105 | 0.180 |
Why?
|
Massachusetts | 5 | 2021 | 8830 | 0.180 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 2273 | 0.170 |
Why?
|
Drug Resistance, Microbial | 2 | 2023 | 825 | 0.170 |
Why?
|
Ohio | 1 | 2020 | 322 | 0.170 |
Why?
|
Fees and Charges | 1 | 2021 | 192 | 0.170 |
Why?
|
Michigan | 1 | 2020 | 339 | 0.170 |
Why?
|
Streptococcal Infections | 1 | 2024 | 617 | 0.170 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2020 | 166 | 0.160 |
Why?
|
Frail Elderly | 2 | 2024 | 765 | 0.160 |
Why?
|
Electronic Mail | 1 | 2020 | 213 | 0.160 |
Why?
|
Students | 2 | 2019 | 1741 | 0.160 |
Why?
|
Homicide | 1 | 2021 | 294 | 0.150 |
Why?
|
Hospitals, Psychiatric | 1 | 2019 | 321 | 0.150 |
Why?
|
Seasons | 1 | 2024 | 1520 | 0.150 |
Why?
|
Cyclonic Storms | 1 | 2019 | 116 | 0.150 |
Why?
|
Medical Audit | 1 | 2019 | 453 | 0.150 |
Why?
|
United States Department of Veterans Affairs | 2 | 2019 | 928 | 0.140 |
Why?
|
Poverty | 2 | 2021 | 2698 | 0.140 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2020 | 370 | 0.140 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 324 | 0.140 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2017 | 92 | 0.140 |
Why?
|
Professional Practice | 1 | 2019 | 313 | 0.140 |
Why?
|
Cost Control | 1 | 2019 | 628 | 0.140 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 166 | 0.140 |
Why?
|
Los Angeles | 1 | 2017 | 243 | 0.140 |
Why?
|
Logistic Models | 3 | 2017 | 13255 | 0.140 |
Why?
|
Wounds and Injuries | 2 | 2021 | 2491 | 0.130 |
Why?
|
Adolescent | 8 | 2024 | 88319 | 0.130 |
Why?
|
Age Factors | 3 | 2018 | 18395 | 0.130 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 532 | 0.130 |
Why?
|
Accidents, Traffic | 1 | 2021 | 816 | 0.130 |
Why?
|
Politics | 1 | 2022 | 815 | 0.120 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1668 | 0.120 |
Why?
|
Behavior, Addictive | 1 | 2020 | 462 | 0.120 |
Why?
|
Neoplasms | 1 | 2024 | 22170 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 559 | 0.120 |
Why?
|
Safety Management | 1 | 2020 | 760 | 0.120 |
Why?
|
Prescription Drugs | 1 | 2022 | 631 | 0.120 |
Why?
|
Risk Assessment | 4 | 2022 | 23995 | 0.120 |
Why?
|
Professional Role | 1 | 2017 | 314 | 0.120 |
Why?
|
Needs Assessment | 1 | 2020 | 1139 | 0.120 |
Why?
|
California | 1 | 2018 | 1429 | 0.120 |
Why?
|
Documentation | 1 | 2020 | 897 | 0.110 |
Why?
|
Community Networks | 2 | 2013 | 201 | 0.110 |
Why?
|
Communicable Disease Control | 1 | 2020 | 846 | 0.110 |
Why?
|
Clostridium Infections | 2 | 2017 | 558 | 0.110 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2019 | 3708 | 0.110 |
Why?
|
Reimbursement, Incentive | 1 | 2018 | 543 | 0.110 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2421 | 0.110 |
Why?
|
Social Stigma | 1 | 2019 | 769 | 0.110 |
Why?
|
Lower Extremity | 1 | 2020 | 1202 | 0.100 |
Why?
|
Independent Living | 1 | 2017 | 579 | 0.100 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1156 | 0.100 |
Why?
|
Social Class | 1 | 2021 | 2004 | 0.100 |
Why?
|
Health Facility Size | 1 | 2012 | 61 | 0.100 |
Why?
|
Medicare Part D | 1 | 2017 | 355 | 0.100 |
Why?
|
Epidemics | 1 | 2017 | 512 | 0.100 |
Why?
|
Contracts | 1 | 2012 | 60 | 0.100 |
Why?
|
Health Services | 1 | 2017 | 752 | 0.100 |
Why?
|
Public Health | 2 | 2023 | 2669 | 0.100 |
Why?
|
Child | 7 | 2024 | 80153 | 0.090 |
Why?
|
Homes for the Aged | 2 | 2024 | 272 | 0.090 |
Why?
|
Time Factors | 3 | 2023 | 39967 | 0.090 |
Why?
|
Bacterial Infections | 1 | 2018 | 1390 | 0.090 |
Why?
|
Suicide | 1 | 2021 | 1601 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1739 | 0.090 |
Why?
|
Hospitals, Urban | 1 | 2012 | 500 | 0.080 |
Why?
|
Integrin beta3 | 1 | 2010 | 120 | 0.080 |
Why?
|
Vaccination | 1 | 2021 | 3384 | 0.080 |
Why?
|
Health Care Reform | 1 | 2018 | 1247 | 0.080 |
Why?
|
Ownership | 1 | 2012 | 339 | 0.080 |
Why?
|
Regression Analysis | 1 | 2018 | 6343 | 0.080 |
Why?
|
Family | 1 | 2020 | 3194 | 0.080 |
Why?
|
Pain Measurement | 1 | 2019 | 3550 | 0.080 |
Why?
|
Disabled Persons | 1 | 2018 | 1225 | 0.080 |
Why?
|
Critical Care | 1 | 2021 | 2696 | 0.080 |
Why?
|
Acute Disease | 2 | 2021 | 7237 | 0.080 |
Why?
|
Hospital Administration | 1 | 2012 | 353 | 0.080 |
Why?
|
Sepsis | 1 | 2022 | 2585 | 0.080 |
Why?
|
Cross Infection | 1 | 2017 | 1422 | 0.070 |
Why?
|
Environmental Exposure | 1 | 2022 | 4486 | 0.070 |
Why?
|
Mental Health Services | 1 | 2018 | 1730 | 0.070 |
Why?
|
Heart Arrest | 1 | 2017 | 1514 | 0.070 |
Why?
|
Area Under Curve | 1 | 2011 | 1638 | 0.070 |
Why?
|
Fracture Healing | 1 | 2010 | 445 | 0.070 |
Why?
|
Tibial Fractures | 1 | 2010 | 273 | 0.070 |
Why?
|
Patient Care | 1 | 2012 | 622 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2017 | 5247 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11121 | 0.060 |
Why?
|
Choice Behavior | 1 | 2011 | 824 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9610 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3416 | 0.060 |
Why?
|
Odds Ratio | 1 | 2017 | 9646 | 0.060 |
Why?
|
Quality of Life | 2 | 2024 | 13367 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3889 | 0.060 |
Why?
|
Cognition | 2 | 2024 | 6990 | 0.060 |
Why?
|
Pain | 1 | 2019 | 5073 | 0.060 |
Why?
|
Ventral Thalamic Nuclei | 1 | 2024 | 43 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14666 | 0.060 |
Why?
|
Health Care Costs | 1 | 2017 | 3242 | 0.060 |
Why?
|
High-Intensity Focused Ultrasound Ablation | 1 | 2024 | 40 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2014 | 1421 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12059 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12974 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2021 | 22176 | 0.050 |
Why?
|
ROC Curve | 1 | 2011 | 3579 | 0.050 |
Why?
|
Hospital Mortality | 1 | 2017 | 5294 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5840 | 0.050 |
Why?
|
Orphenadrine | 1 | 2022 | 4 | 0.050 |
Why?
|
Chlorzoxazone | 1 | 2022 | 7 | 0.050 |
Why?
|
Interviews as Topic | 2 | 2020 | 2696 | 0.050 |
Why?
|
Patient Care Team | 1 | 2014 | 2521 | 0.050 |
Why?
|
Hydrocodone | 1 | 2022 | 48 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6935 | 0.050 |
Why?
|
Amitriptyline | 1 | 2022 | 112 | 0.050 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2021 | 33 | 0.050 |
Why?
|
Chronic Disease | 1 | 2017 | 9318 | 0.050 |
Why?
|
Methadone | 1 | 2024 | 321 | 0.050 |
Why?
|
Insurance Claim Review | 2 | 2018 | 741 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7827 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10552 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7390 | 0.050 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2021 | 56 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2023 | 39106 | 0.050 |
Why?
|
Electronics | 1 | 2022 | 318 | 0.050 |
Why?
|
Muscle Relaxants, Central | 1 | 2021 | 93 | 0.040 |
Why?
|
Risk Factors | 4 | 2021 | 74206 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8540 | 0.040 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2021 | 448 | 0.040 |
Why?
|
Child, Preschool | 3 | 2024 | 42230 | 0.040 |
Why?
|
Rehabilitation | 1 | 2020 | 130 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20098 | 0.040 |
Why?
|
Boston | 1 | 2011 | 9326 | 0.040 |
Why?
|
Financial Management, Hospital | 1 | 2018 | 70 | 0.040 |
Why?
|
Substance Abuse Detection | 1 | 2020 | 301 | 0.040 |
Why?
|
Clinical Coding | 1 | 2018 | 181 | 0.040 |
Why?
|
Insurance | 1 | 2018 | 113 | 0.040 |
Why?
|
General Practitioners | 1 | 2018 | 101 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 2022 | 819 | 0.030 |
Why?
|
Drug Interactions | 1 | 2021 | 1416 | 0.030 |
Why?
|
Minority Groups | 1 | 2024 | 1203 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36426 | 0.030 |
Why?
|
Physicians, Family | 1 | 2018 | 350 | 0.030 |
Why?
|
Infant | 2 | 2024 | 36192 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2024 | 64680 | 0.030 |
Why?
|
Workplace | 1 | 2021 | 863 | 0.030 |
Why?
|
Perception | 1 | 2021 | 1197 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21012 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2021 | 1179 | 0.030 |
Why?
|
Peer Group | 1 | 2018 | 692 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21353 | 0.030 |
Why?
|
Income | 1 | 2021 | 1877 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2012 | 26198 | 0.020 |
Why?
|
Internal Medicine | 1 | 2018 | 1051 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6310 | 0.020 |
Why?
|
Bony Callus | 1 | 2010 | 41 | 0.020 |
Why?
|
Qualitative Research | 1 | 2020 | 3023 | 0.020 |
Why?
|
Comorbidity | 1 | 2023 | 10508 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3201 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6484 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8631 | 0.020 |
Why?
|
Cartilage | 1 | 2010 | 806 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15732 | 0.010 |
Why?
|
Tibia | 1 | 2010 | 1070 | 0.010 |
Why?
|
Decision Making | 1 | 2012 | 3929 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14414 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 14031 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18252 | 0.010 |
Why?
|
Mice | 1 | 2010 | 81525 | 0.000 |
Why?
|
Animals | 1 | 2010 | 168459 | 0.000 |
Why?
|